Report Thumbnail
Product Code LP091290948F0Z
Published Date 2024/1/4
English146 PagesGlobal

Global BCI and EEG Market Growth (Status and Outlook) 2024-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP091290948F0Z◆The Jan 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2024/1/4
English 146 PagesGlobal

Global BCI and EEG Market Growth (Status and Outlook) 2024-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

According to our LPI (LP Information) latest study, the global BCI and EEG market size was valued at US$ 689.7 million in 2023. With growing demand in downstream market, the BCI and EEG is forecast to a readjusted size of US$ 1367.2 million by 2030 with a CAGR of 10.3% during review period.
The research report highlights the growth potential of the global BCI and EEG market. BCI and EEG are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of BCI and EEG. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the BCI and EEG market.
This report covers market analysis of BCI and EGG. A brain–computer interface (BCI), sometimes called a neural-control interface (NCI), mind-machine interface (MMI), direct neural interface (DNI), or brain–machine interface (BMI), is a direct communication pathway between an enhanced or wired brain and an external device.
An EEG, or electroencephalogram, is a test that records the electrical signals of the brain. Doctors use it to help diagnose epilepsy and sleep disorders.
Global BCI and EEG main manufactuers include Medtronic, Natus Medical, Nihon Kohden, NeuroPace Inc and Mindmaze SA, totally accounting for about 45% of the market. North America is the largest market of BCI and EEG, holding a share about 40%. As for the application of products, it is widely used in medical and consumer field. The most common application is in medical field, with a share about 80%. As for the types of products, it can be divided into Hardware and Software and Service. The most common type is Hardware, with a share over 77%.
Key Features:
The report on BCI and EEG market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the BCI and EEG market. It may include historical data, market segmentation by Type (e.g., Hardware, Software and Service), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the BCI and EEG market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the BCI and EEG market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the BCI and EEG industry. This include advancements in BCI and EEG technology, BCI and EEG new entrants, BCI and EEG new investment, and other innovations that are shaping the future of BCI and EEG.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the BCI and EEG market. It includes factors influencing customer ' purchasing decisions, preferences for BCI and EEG product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the BCI and EEG market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting BCI and EEG market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the BCI and EEG market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the BCI and EEG industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the BCI and EEG market.
Market Segmentation:
BCI and EEG market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Hardware
Software and Service
Segmentation by application
Medical
Consumer
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Natus Medical
Nihon Kohden
NeuroPace Inc
Mindmaze SA
G.TEC
BrainCo
InteraXon
Brain Products GmbH
EGI
Blackrock Microsystems LLC
Emotiv Inc
Micromed
ANT Neuro B.V
Compumedics Limited
NeuroSky, Inc.
Artinis Medical Systems BV
Cadwell
Advanced Brain Monitoring
NCC Medical
SYMTOP
Neuroelectrics

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global BCI and EEG Market Size 2019-2030
      • 2.1.2 BCI and EEG Market Size CAGR by Region 2019 VS 2023 VS 2030
    • 2.2 BCI and EEG Segment by Type
      • 2.2.1 Hardware
      • 2.2.2 Software and Service
    • 2.3 BCI and EEG Market Size by Type
      • 2.3.1 BCI and EEG Market Size CAGR by Type (2019 VS 2023 VS 2030)
      • 2.3.2 Global BCI and EEG Market Size Market Share by Type (2019-2024)
    • 2.4 BCI and EEG Segment by Application
      • 2.4.1 Medical
      • 2.4.2 Consumer
    • 2.5 BCI and EEG Market Size by Application
      • 2.5.1 BCI and EEG Market Size CAGR by Application (2019 VS 2023 VS 2030)
      • 2.5.2 Global BCI and EEG Market Size Market Share by Application (2019-2024)
  • 3 BCI and EEG Market Size by Player

    • 3.1 BCI and EEG Market Size Market Share by Players
      • 3.1.1 Global BCI and EEG Revenue by Players (2019-2024)
      • 3.1.2 Global BCI and EEG Revenue Market Share by Players (2019-2024)
    • 3.2 Global BCI and EEG Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 BCI and EEG by Regions

    • 4.1 BCI and EEG Market Size by Regions (2019-2024)
    • 4.2 Americas BCI and EEG Market Size Growth (2019-2024)
    • 4.3 APAC BCI and EEG Market Size Growth (2019-2024)
    • 4.4 Europe BCI and EEG Market Size Growth (2019-2024)
    • 4.5 Middle East & Africa BCI and EEG Market Size Growth (2019-2024)
  • 5 Americas

    • 5.1 Americas BCI and EEG Market Size by Country (2019-2024)
    • 5.2 Americas BCI and EEG Market Size by Type (2019-2024)
    • 5.3 Americas BCI and EEG Market Size by Application (2019-2024)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC BCI and EEG Market Size by Region (2019-2024)
    • 6.2 APAC BCI and EEG Market Size by Type (2019-2024)
    • 6.3 APAC BCI and EEG Market Size by Application (2019-2024)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe BCI and EEG by Country (2019-2024)
    • 7.2 Europe BCI and EEG Market Size by Type (2019-2024)
    • 7.3 Europe BCI and EEG Market Size by Application (2019-2024)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa BCI and EEG by Region (2019-2024)
    • 8.2 Middle East & Africa BCI and EEG Market Size by Type (2019-2024)
    • 8.3 Middle East & Africa BCI and EEG Market Size by Application (2019-2024)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global BCI and EEG Market Forecast

    • 10.1 Global BCI and EEG Forecast by Regions (2025-2030)
      • 10.1.1 Global BCI and EEG Forecast by Regions (2025-2030)
      • 10.1.2 Americas BCI and EEG Forecast
      • 10.1.3 APAC BCI and EEG Forecast
      • 10.1.4 Europe BCI and EEG Forecast
      • 10.1.5 Middle East & Africa BCI and EEG Forecast
    • 10.2 Americas BCI and EEG Forecast by Country (2025-2030)
      • 10.2.1 United States BCI and EEG Market Forecast
      • 10.2.2 Canada BCI and EEG Market Forecast
      • 10.2.3 Mexico BCI and EEG Market Forecast
      • 10.2.4 Brazil BCI and EEG Market Forecast
    • 10.3 APAC BCI and EEG Forecast by Region (2025-2030)
      • 10.3.1 China BCI and EEG Market Forecast
      • 10.3.2 Japan BCI and EEG Market Forecast
      • 10.3.3 Korea BCI and EEG Market Forecast
      • 10.3.4 Southeast Asia BCI and EEG Market Forecast
      • 10.3.5 India BCI and EEG Market Forecast
      • 10.3.6 Australia BCI and EEG Market Forecast
    • 10.4 Europe BCI and EEG Forecast by Country (2025-2030)
      • 10.4.1 Germany BCI and EEG Market Forecast
      • 10.4.2 France BCI and EEG Market Forecast
      • 10.4.3 UK BCI and EEG Market Forecast
      • 10.4.4 Italy BCI and EEG Market Forecast
      • 10.4.5 Russia BCI and EEG Market Forecast
    • 10.5 Middle East & Africa BCI and EEG Forecast by Region (2025-2030)
      • 10.5.1 Egypt BCI and EEG Market Forecast
      • 10.5.2 South Africa BCI and EEG Market Forecast
      • 10.5.3 Israel BCI and EEG Market Forecast
      • 10.5.4 Turkey BCI and EEG Market Forecast
      • 10.5.5 GCC Countries BCI and EEG Market Forecast
    • 10.6 Global BCI and EEG Forecast by Type (2025-2030)
    • 10.7 Global BCI and EEG Forecast by Application (2025-2030)
  • 11 Key Players Analysis

    • 11.1 Medtronic
      • 11.1.1 Medtronic Company Information
      • 11.1.2 Medtronic BCI and EEG Product Offered
      • 11.1.3 Medtronic BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.1.4 Medtronic Main Business Overview
      • 11.1.5 Medtronic Latest Developments
    • 11.2 Natus Medical
      • 11.2.1 Natus Medical Company Information
      • 11.2.2 Natus Medical BCI and EEG Product Offered
      • 11.2.3 Natus Medical BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.2.4 Natus Medical Main Business Overview
      • 11.2.5 Natus Medical Latest Developments
    • 11.3 Nihon Kohden
      • 11.3.1 Nihon Kohden Company Information
      • 11.3.2 Nihon Kohden BCI and EEG Product Offered
      • 11.3.3 Nihon Kohden BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.3.4 Nihon Kohden Main Business Overview
      • 11.3.5 Nihon Kohden Latest Developments
    • 11.4 NeuroPace Inc
      • 11.4.1 NeuroPace Inc Company Information
      • 11.4.2 NeuroPace Inc BCI and EEG Product Offered
      • 11.4.3 NeuroPace Inc BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.4.4 NeuroPace Inc Main Business Overview
      • 11.4.5 NeuroPace Inc Latest Developments
    • 11.5 Mindmaze SA
      • 11.5.1 Mindmaze SA Company Information
      • 11.5.2 Mindmaze SA BCI and EEG Product Offered
      • 11.5.3 Mindmaze SA BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.5.4 Mindmaze SA Main Business Overview
      • 11.5.5 Mindmaze SA Latest Developments
    • 11.6 G.TEC
      • 11.6.1 G.TEC Company Information
      • 11.6.2 G.TEC BCI and EEG Product Offered
      • 11.6.3 G.TEC BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.6.4 G.TEC Main Business Overview
      • 11.6.5 G.TEC Latest Developments
    • 11.7 BrainCo
      • 11.7.1 BrainCo Company Information
      • 11.7.2 BrainCo BCI and EEG Product Offered
      • 11.7.3 BrainCo BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.7.4 BrainCo Main Business Overview
      • 11.7.5 BrainCo Latest Developments
    • 11.8 InteraXon
      • 11.8.1 InteraXon Company Information
      • 11.8.2 InteraXon BCI and EEG Product Offered
      • 11.8.3 InteraXon BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.8.4 InteraXon Main Business Overview
      • 11.8.5 InteraXon Latest Developments
    • 11.9 Brain Products GmbH
      • 11.9.1 Brain Products GmbH Company Information
      • 11.9.2 Brain Products GmbH BCI and EEG Product Offered
      • 11.9.3 Brain Products GmbH BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.9.4 Brain Products GmbH Main Business Overview
      • 11.9.5 Brain Products GmbH Latest Developments
    • 11.10 EGI
      • 11.10.1 EGI Company Information
      • 11.10.2 EGI BCI and EEG Product Offered
      • 11.10.3 EGI BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.10.4 EGI Main Business Overview
      • 11.10.5 EGI Latest Developments
    • 11.11 Blackrock Microsystems LLC
      • 11.11.1 Blackrock Microsystems LLC Company Information
      • 11.11.2 Blackrock Microsystems LLC BCI and EEG Product Offered
      • 11.11.3 Blackrock Microsystems LLC BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.11.4 Blackrock Microsystems LLC Main Business Overview
      • 11.11.5 Blackrock Microsystems LLC Latest Developments
    • 11.12 Emotiv Inc
      • 11.12.1 Emotiv Inc Company Information
      • 11.12.2 Emotiv Inc BCI and EEG Product Offered
      • 11.12.3 Emotiv Inc BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.12.4 Emotiv Inc Main Business Overview
      • 11.12.5 Emotiv Inc Latest Developments
    • 11.13 Micromed
      • 11.13.1 Micromed Company Information
      • 11.13.2 Micromed BCI and EEG Product Offered
      • 11.13.3 Micromed BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.13.4 Micromed Main Business Overview
      • 11.13.5 Micromed Latest Developments
    • 11.14 ANT Neuro B.V
      • 11.14.1 ANT Neuro B.V Company Information
      • 11.14.2 ANT Neuro B.V BCI and EEG Product Offered
      • 11.14.3 ANT Neuro B.V BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.14.4 ANT Neuro B.V Main Business Overview
      • 11.14.5 ANT Neuro B.V Latest Developments
    • 11.15 Compumedics Limited
      • 11.15.1 Compumedics Limited Company Information
      • 11.15.2 Compumedics Limited BCI and EEG Product Offered
      • 11.15.3 Compumedics Limited BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.15.4 Compumedics Limited Main Business Overview
      • 11.15.5 Compumedics Limited Latest Developments
    • 11.16 NeuroSky, Inc.
      • 11.16.1 NeuroSky, Inc. Company Information
      • 11.16.2 NeuroSky, Inc. BCI and EEG Product Offered
      • 11.16.3 NeuroSky, Inc. BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.16.4 NeuroSky, Inc. Main Business Overview
      • 11.16.5 NeuroSky, Inc. Latest Developments
    • 11.17 Artinis Medical Systems BV
      • 11.17.1 Artinis Medical Systems BV Company Information
      • 11.17.2 Artinis Medical Systems BV BCI and EEG Product Offered
      • 11.17.3 Artinis Medical Systems BV BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.17.4 Artinis Medical Systems BV Main Business Overview
      • 11.17.5 Artinis Medical Systems BV Latest Developments
    • 11.18 Cadwell
      • 11.18.1 Cadwell Company Information
      • 11.18.2 Cadwell BCI and EEG Product Offered
      • 11.18.3 Cadwell BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.18.4 Cadwell Main Business Overview
      • 11.18.5 Cadwell Latest Developments
    • 11.19 Advanced Brain Monitoring
      • 11.19.1 Advanced Brain Monitoring Company Information
      • 11.19.2 Advanced Brain Monitoring BCI and EEG Product Offered
      • 11.19.3 Advanced Brain Monitoring BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.19.4 Advanced Brain Monitoring Main Business Overview
      • 11.19.5 Advanced Brain Monitoring Latest Developments
    • 11.20 NCC Medical
      • 11.20.1 NCC Medical Company Information
      • 11.20.2 NCC Medical BCI and EEG Product Offered
      • 11.20.3 NCC Medical BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.20.4 NCC Medical Main Business Overview
      • 11.20.5 NCC Medical Latest Developments
    • 11.21 SYMTOP
      • 11.21.1 SYMTOP Company Information
      • 11.21.2 SYMTOP BCI and EEG Product Offered
      • 11.21.3 SYMTOP BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.21.4 SYMTOP Main Business Overview
      • 11.21.5 SYMTOP Latest Developments
    • 11.22 Neuroelectrics
      • 11.22.1 Neuroelectrics Company Information
      • 11.22.2 Neuroelectrics BCI and EEG Product Offered
      • 11.22.3 Neuroelectrics BCI and EEG Revenue, Gross Margin and Market Share (2019-2024)
      • 11.22.4 Neuroelectrics Main Business Overview
      • 11.22.5 Neuroelectrics Latest Developments
  • 12 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.